This acquisition expands Sage’s offerings in repair services, which it says bolsters its existing ITAD services.

Sage is lopping off one-third of its workforce after one of its experimental drugs failed to prove effective as a treatment ...

On Thursday, Sage Therapeutics, Inc. (NASDAQ:SAGE) announced a strategic reorganization of its business operations to support ...

After a year of disappointing drug trial results, Sage Therapeutics Inc. is slashing its headcount and shaking up its ...

Sage Therapeutics said on Thursday its finance chief will leave the company and the drugmaker plans to lay off more than 165 ...

Sage Therapeutics Inc.’s stock slid 4.7% Thursday, after the biotech said it’s cutting about 33% of its workforce as part of ...

The new hires bring global partnership and marketing expertise to support its mission of financial wellbeing and credit ...

CAMBRIDGE, Mass. - Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company, has announced a significant reorganization of its operations, which includes a workforce reduction impacting ...

Sage Therapeutics Inc. is laying off more than 165 employees as the biotech company tries to conserve cash after multiple ...

Sage and Biogen last year won Food and Drug Administration approval of Zurzuvae as the first pill to treat postpartum depression, but the agency rejected the drug for major depressive disorder, a much ...

Based in Columbus, Ohio, Sage is a provider of IT asset disposition services, safely and securely refurbishing used IT assets for another life.